1
Clinical Trials associated with GSK-3884464A Two-Part First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Oral Doses of GSK3884464 in a Randomized, Double Blind, Placebo-Controlled, Dose Escalation Study in Healthy Participants
This will be a FTIH study which aims to evaluate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and repeat oral doses of GSK3884464 administered to healthy participants.
100 Clinical Results associated with GSK-3884464
100 Translational Medicine associated with GSK-3884464
100 Patents (Medical) associated with GSK-3884464
100 Deals associated with GSK-3884464